_erin-futrell-talks-about-her-research-while-in-the-phd-in-rehabilitation-sciences-program.jpg "Erin Futrell talks about her research while in the PhD in Rehabilitation Sciences program. from mgh Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1 min 29 sec
✓ Published: 10-May-2018
✓ Published: 10-May-2018
Description:
Erin Futrell talks about her research in the PhD in Rehabilitation Sciences program. Her current research setting is in the The Spaulding National Running Center (SNRC), Cambridge, MA under mentor Dr. Irene Davis. Erin's research is focused on the ability of patients with running injuries to learn new gait styles aimed at reducing impacts. For more information visit: www.mghihp.edu/phd
Erin Futrell talks about her research in the PhD in Rehabilitation Sciences program. Her current research setting is in the The Spaulding National Running Center (SNRC), Cambridge, MA under mentor Dr. Irene Davis. Erin's research is focused on the ability of patients with running injuries to learn new gait styles aimed at reducing impacts. For more information visit: www.mghihp.edu/phd
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_lisa-feldman-barrett-mgh-psychiatry-grand-rounds.webp "Lisa Feldman Barrett - MGH Psychiatry Grand Rounds from mgh")
_assertive-psychosocial-rehabilitation-mgh-psychiatry-academy.webp "Corrine Cather, PhDnSchizophrenia Clinical and Research ProgramnMassachusetts General Hospital")
_mia-julia-medley-im-qu-club-mgh.webp "Mia Julia LIVE im QU Club Bad Mergentheim")
_radicava-a-review-of-clinical-trial-data-and-drug-considerations.webp "Radicava (edaravone) is a drug that was approved by the U.S. Food and Drug Administration (FDA) to treat people with ALS in May of 2017. Dr. Jonathan Glass, Emory University, opens the presentation with a summary of the clinical trial data that led to the FDA approval of Radicava, and Darlene Sawicki, Massachusetts General Hospital, discusses the pros and cons of choosing Radicava, as well as details about obtaining the drug.")
_hon-roanne-sragow-judge39s-perspective.webp "Part of")
_topcare-a-population-health-management-solution-powered-by-blenderhealth.webp "SRG Technology has partnered with Massachusetts General Hospital’s Laboratory of Computer Science (MGH LCS) to build a Population Health Management (PHM) solution with the common goal of improving clinical process, patient outcomes and the cost effectiveness of care.The video is a condensed version of our PHM presentation.")
⏲ 5 min 82 sec ✓ 06-Nov-2013
_gladwell-amp-smoller-on-telling-a-good-story.webp "Part of")
_carey-mgh.webp "Carey - MGH from mgh")
_lisa-feldman-barrett-mgh-psychiatry-grand-rounds.jpg)
_assertive-psychosocial-rehabilitation-mgh-psychiatry-academy.jpg)
_mia-julia-medley-im-qu-club-mgh.jpg)
_radicava-a-review-of-clinical-trial-data-and-drug-considerations.jpg)
_hon-roanne-sragow-judge39s-perspective.jpg)
_topcare-a-population-health-management-solution-powered-by-blenderhealth.jpg)
_gladwell-amp-smoller-on-telling-a-good-story.jpg)
_carey-mgh.jpg)
![[+]](/images/menu.gif){kind=small}